CANCER OF PANCREAS
Clinical trials for CANCER OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New program aims to bridge gap between cancer and heart care
Disease control OngoingThis study tests a new program designed to improve teamwork between cancer doctors and primary care doctors. It focuses on helping cancer survivors who also have high blood pressure, diabetes, or high cholesterol manage these conditions better during and after cancer treatment. T…
Matched conditions: CANCER OF PANCREAS
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
New oral cancer drug enters first human trials for Tough-to-Treat mutation
Disease control OngoingThis early-stage study is testing a new oral medication called HBI-2438 in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find the highest safe dose and understand how the body processes the drug. It includes 44 adult…
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New cancer pill targets KRAS and EGFR mutations in early human trial
Disease control OngoingThis early-stage study is testing a new oral medication called HBI-2376 in people with advanced solid tumors that have specific KRAS or EGFR mutations. The main goals are to find the highest safe dose of the drug and to understand how the body absorbs and processes it. The trial …
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC